|本期目录/Table of Contents|

[1]李剑瑜 刘鹏年 张霞等.三七皂甙Rg1、Rb1对肝纤维化大鼠线粒体DNA三磷酸腺苷酶6、8亚基的作用机制研究[J].环球中医药,2014,7(08):591-0.
 LI Jian-yu,LIU Peng-nian,ZHANG Xia,et al.Study on the mitochondrial mtDNA ATPase6、8 gene mutation and on the function mechanism of panax notoginseng saponins Rg1,Rb1 for hepatic fibrosis rats[J].,2014,7(08):591-0.
点击复制

三七皂甙Rg1、Rb1对肝纤维化大鼠线粒体DNA三磷酸腺苷酶6、8亚基的作用机制研究()
     
分享到:

《环球中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
第7卷
期数:
2014年08期
页码:
591-0
栏目:
论著
出版日期:
2014-08-06

文章信息/Info

Title:
Study on the mitochondrial mtDNA ATPase6、8 gene mutation and on the function mechanism of panax notoginseng saponins Rg1,Rb1 for hepatic fibrosis rats
作者:
李剑瑜 刘鹏年 张霞等
Author(s):
LI Jian-yu LIU Peng-nian ZHANG Xia et al.
Blood Transfusion Department of Zhuozhou City Hospital, Zhuozhou 072750, China
关键词:
肝纤维化线粒体三磷酸腺苷酶6亚基三磷酸腺苷酶8亚基三七皂甙Rg1三七皂甙Rb1Wistar大鼠
Keywords:
Hepatic fibrosis Mitochondria DNA Adenosine triphosphatase 6 gene Adenosine triphosphatase 8 gene Panax notoginseng saponins Rg1 Panax notoginseng saponins Rb1 Wistar rat
分类号:
-
DOI:
-
文献标志码:
A
摘要:
目的 探讨三七皂甙(panax notoginseng saponins,PnS)Rg1、PnS Rb1干预下,肝纤维化大鼠线粒体DNA三磷酸腺苷(adenine triphosphate,ATP)酶6亚基、ATP酶8亚基的基因突变和ATP含量变化。方法 96只Wistar大鼠分为对照组、四氯化碳(carbon tetrachloride,CCl4)肝纤维化大鼠模型组、PnS Rg1组、PnS Rb1组各24只。除对照组外,其余3组用5%CCl4橄榄油按5 ml/kg灌胃制作肝纤维化大鼠模型。PnS Rg1组在每次CCl4灌胃同时腹腔注射PnSRg1(5 mg/kg)。PnS Rb1组在每次C...
Abstract:
Objective To explore the changes of the mitochondrial DNA(mt DNA)adenine triphospholibase(ATPase)6 gene, ATPase 8 gene mutation under the intervention of panax notoginseng saponins(PnS)Rg1, PnS Rb1 for hepatic fibrosis rats which may have theoretical sense in the prevention and cure hepatic fibrosis. Methods 96 Wistar rats divided into contrast group,carbon tetrachloride(CCl4 )group, liver fibrosis rats model group, PnS Rg1 group and PnS Rb1group, with 24 rats in each group.Except contrast group, other three groups were reproduced by repeated injection 5% CCl4 solution in rats into liver fibrosis rats model. PnS Rg1 group were also injected 5 ml/kg, PnS Rb1 group were injected 5 ml/kg, and at the same time given 5% CCl4 solution. Extract RNA of hepatic mitochondrial and reverse transcription complementary DNA(cDNA). Gene-recommended and sequencing have been researched. Then further study the PnS Rg1 group, PnS Rb1 group ATPase 6 gene 7904-8584 region and ATPase 8 gene 7743-7946 region gene mutation after 6 weeks. Biological fluorescent method detect ATP content.Results(1)Compare with the contrast group, gene analysis of mtDNA ATPase 6 in hepatic fibrosis of model group rats showed that there were three mutation sites:C8294G, T8505G, C8584A. Using Fisher's exact test to analyze, mutations have increased significantly(P<0.01). Compare with the contrast group, PnS Rg1 group、PnS Rb1 group mutation increasing does not have marked sense(P>0.05).(2)Compare with the contrast group,the gene analysis of mtDNA ATPase 8 were two mutation sites: A7797non, T7863C. Using Fisher's exact test to analyze, mutations have increased significantly(P<0.01).(3)Liver fibrosis rats mitochondrial DNA ATP of each group with CCl4 manage time correlation analysis, undergoing pearson's test r=-0.935 negative correlation.(4)Liver fibrosis rats mitochondrial DNA ATP of each group with ATPase6 gene mutation has correlation analysis, undergoing pearson's test r=-0.943 negative correlation. Liver fibrosis rats mitochondrial DNA ATP of each group with ATPase8 gene mutation has correlation analysis, undergoing pearson's test r=-0.961 negative correlation.Conclusion The mutation of mtDNA ATPase 6 gene and ATPase 8 gene may be responsible for hepatic fibrosis development. PnS Rg1,PnS Rb1 were protective function remarkably for the mitochondrial of hepatic fibrosis rats through inhibition of mtDNA ATPase 6 gene, ATPase 8 gene mutation rate. Therefore delay hepatic fibrosis development.

参考文献/References:

[1] Arduini A, Serviddio G, Escobar J,et al. Mitochondrial biogenesis fails in secondary biliary cirrhosis in rats leading to mitochondrial DNA depletion and deletions[J]. Am J Physiol Gastrointest Liver Physiol, 2011,301(1): 119- 27.
[2] Banasch M, Ellrichmann M, Tannapfel A, et al. The non-invasive(13)C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis[J]. Eur J Med Res, 2011, 16(6):258- 64.
[3] Williams EJ, Benyon RC, Trim N, et al. Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo[J]. Gut, 2001, 49(4): 577- 583.
[4] Soroida Y, Ohkawa R, Nakagawa H, et al. Increased activity of serum mitochondrial isoenzyme of creatine kinase in hepatocellular carcinoma patients predominantly with recurrence[J]. J Hepatol,2012,57(2):330- 336.
[5] Mancuso M, Ferraris S, Pancrudo J, et al.New DGK gene mutations in the hepatocerebral form of mitochondrial DNA depletion syndrome[J]. Arch Neurol, 2005,62(5):745- 747.
[6] Uusimaa J, Finnilä S, Vainionpää L,et al. A mutation in mitochondrial DNA-encoded cytochrome c oxidase II gene in a child with Alpers-Huttenlocher-like disease[J]. Pediatrics, 2003,111(3):e262- 268.
[7] Fukushima S, Honda K, Awane M, et al. The frequency of 4977 base pair deletion of mitochondrial DNA in various types of liverdisease and in normal liver[J]. Hepatology, 1995,21(6):1547-51.
[8] Levéen P, Kotarsky H, Mörgelin M, et al. he GRACILE mutation introduced into Bcs1l causes postnatal complex III deficiency: a viable mouTse model for mitochondrial hepatopathy[J]. Hepatology,2011,53(2):437- 447.
[9] Mancuso M, Ferraris S, Pancrudo J, et al. New DGK gene mutations in the hepatocerebral form of mitochondrial DNA depletion syndrome[J].Arch Neurol, 2005,62(5):745- 747.
[10] McDonald DG, McMenamin JB, Farrell MA, et al. Familial childhood onset neuropathy and cirrhosis with the 4977bp mitochondrial DNA deletion[J].Am J Med Genet,2002,111(2):191- 194.
[11] Massoud Houshmand, Sadaf Kasraie, Solmaz Etemad Ahari, et al. Investigation of tRNALys/Leu and ATPase 6/8 gene mutations in Iranian ataxia telangiectasia patients[J].Arch Med Sci, 2011,7(3): 523- 527.

相似文献/References:

[1]徐晨光 闫洁 陈蓝羽 李娟梅 吕文良.丹参有效成分抗肝纤维化作用机制的研究进展[J].环球中医药,2013,6(04):305.
 XU Chen guang,YAN Jie,CHEN Lan yu,et al.Research progress in antihepatic fibrosis mechanism of Salvia Miltiorrhiza[J].,2013,6(08):305.
[2]李川,吕文良.常见中药复方制剂抗肝纤维化机制研究进展[J].环球中医药,2013,6(01):70.
 LI Chuan,LYU Wen liang..Mechanism research of common Chinese patent medicine antifibrotic[J].,2013,6(08):70.
[3]刘文兰 油红捷 车念聪等.一贯煎促进骨髓间充质干细胞逆转肝纤维化的实验研究[J].环球中医药,2014,7(06):401.
 LIU Wen lan,YOU Hong jie,CHE Nian cong,et al.The promotion of Yiguanjian on the recovery of liver fibrosis through mesenchymal stem cells:an experimental study[J].,2014,7(08):401.
[4]王磊,王惠娟,吴凯,等.茵陈蒿汤改善酒精性肝病大鼠肝脏及小肠病变的组织病理学研究[J].环球中医药,2015,8(11):1329.[doi:10.3969/j.issn.1674-1749.2015.11.014]
 WANG Lei,WANG Hui juan,WU Kai,et al.Effect of Yinchenhao decoction on both hepatic and intestinal histopathology in rats with alcoholic liver disease[J].,2015,8(08):1329.[doi:10.3969/j.issn.1674-1749.2015.11.014]
[5]马羽萍 吴超 王裕云 姚海波.芪归四逆散联合恩替卡韦分散片治疗肝郁脾虚血瘀型慢性乙型肝炎肝纤维化48例[J].环球中医药,2016,9(07):862.[doi:10.3969/j.issn.1674-1749.2016.07.031]
[6]郭雨菲,李雪,迟莉.中药单体抗肝纤维化作用研究进展[J].环球中医药,2016,9(09):1149.[doi:10.3969/j.issn.1674-1749.2016.09.040]
 GUO Yu-fei,LI Xue,CHI Li..Research advance on the effect of Chinese medicine monomer on anti-hepatic fibrosis[J].,2016,9(08):1149.[doi:10.3969/j.issn.1674-1749.2016.09.040]
[7]李剑瑜,刘鹏年,张霞,等.三七皂苷Rg1对肝纤维化大鼠线粒体质子跨膜 转运的作用机制[J].环球中医药,2015,8(05):523.[doi:10.3969/j.issn.16741749.2015.05.003]
 LI Jian yu,LIU Peng nian,ZHANG Xia,et al.Action mechanism of proton translocation across mitochondrial membrane of notoginsenoside Rg1 on hepatic fibrosis rats[J].,2015,8(08):523.[doi:10.3969/j.issn.16741749.2015.05.003]

备注/Memo

备注/Memo:

作者单位:072750 河北省涿州市医院输血科(李剑瑜、刘鹏年、张霞、穆启梅、柳伟、刘强),检验科(武凡)
作者简介:李剑瑜(1973- ),女,本科,副主任技师。研究方向:临床检验。 E-mail:ljy1797@163.com 通讯作者:武凡(1949- ),女,博士,教授。研究方向:细胞损伤与抗损伤。E-mail:wufanfan49@163.com
更新日期/Last Update: 1900-01-01